News

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
Australian company, Touch Biotechnology’s self-testing kit is now available, so you can monitor your sexual health at home. Durex found in their 2025 Australian Sex Survey that 32 per cent of si ...
KAISERSLAUTERN, Germany — Defense Department civilian employees and contractors abroad can no longer get rape test kits done at military medical facilities, a decision that attorneys say will ...
We've not tested that here. For each test, everything except for the product being tested was kept the same, meaning the bike, the rider, cadence, position, other kit, and test protocols remained ...
We have all had a blood test before, but have you ever wondered what happens once the needle is removed and the vial is sent off? At the MUHC Central Laboratory, part of the OPTILAB laboratory network ...
WEDNESDAY, April 16, 2025 (HealthDay News) -- A new blood test can help predict if melanoma survivors will have a future bout with skin cancer, researchers say. The test looks for DNA fragments ...
A major community-based study has shown that blood-based biomarkers such as tau217 ... “This is an encouraging result, especially considering the 10-year predictive window between testing and ...
Giant Food announced Tuesday the launch of a pilot program that provides customers with access to a multi-cancer early-detection blood test. The initiative is part of a partnership with lab test ...
Israeli researchers say they have developed a blood test that can accurately tell whether someone might be developing Parkinson’s – even before they have symptoms. “This discovery is a big ...
That's when I found Thriva. The main benefit of home testing kits is that you’re empowered to do things in your own time. When I go to the doctor, I feel like I have to do the blood test then and ...
The next time oncologists ask for regular blood testing, they can order the Signatera kit as well. Natera then uses that personalized test to look for evidence of that cancer's circulating tumor DNA.
An NHS provider that won a £2bn contract to deliver blood-testing services for hospitals and GPs is failing to deliver reliable results, according to medical professionals. Synnovis, a public ...